Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GERRY A ROSALES

Allopathic & Osteopathic Physicians Family Medicine

NPI
1427227909
CMS profile
246037
Location
RICHBORO, PA

General Payments · PY2018

$324.49

  • Reported across 18 records
  • CMS publication 2026-01-23

Latest program year · PY2018

$324.49

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2018 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $324.49 18

By paying entity

PY2018 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $113.69 5
Acerta Pharma LLC $66.35 4
Novo Nordisk AS $61.21 4
Merck Sharp & Dohme Corporation $28.72 2
Amgen Inc. $21.73 1
Lilly USA, LLC $17.55 1
Boehringer Ingelheim Pharmaceuticals, Inc. $15.24 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $324.49 18

Payment records · PY2018 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2018
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $21.73 04/27/2018 Food and Beverage Undisputed 01/23/2026 567296335 CMS
AstraZeneca Pharmaceuticals LP $17.46 01/10/2018 Food and Beverage Undisputed 01/23/2026 559736343 CMS
AstraZeneca Pharmaceuticals LP $16.20 01/24/2018 Food and Beverage Undisputed 01/23/2026 561846379 CMS
AstraZeneca Pharmaceuticals LP $17.46 04/04/2018 Food and Beverage Undisputed 01/23/2026 560542381 CMS
AstraZeneca Pharmaceuticals LP $15.23 04/18/2018 Food and Beverage Undisputed 01/23/2026 562341965 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.24 02/07/2018 Food and Beverage Undisputed 01/23/2026 577491697 CMS
Lilly USA, LLC $17.55 04/25/2018 Food and Beverage Undisputed 01/23/2026 559323457 CMS
Merck Sharp & Dohme Corporation $14.87 04/04/2018 Food and Beverage Undisputed 01/23/2026 604314347 CMS
Merck Sharp & Dohme Corporation $13.85 06/20/2018 Food and Beverage Undisputed 01/23/2026 604444953 CMS
Novo Nordisk Inc $19.28 02/21/2018 Food and Beverage Undisputed 01/23/2026 588679187 CMS
Novo Nordisk Inc $13.95 05/23/2018 Food and Beverage Undisputed 01/23/2026 588679181 CMS
Novo Nordisk Inc $14.18 06/13/2018 Food and Beverage Undisputed 01/23/2026 588679185 CMS
Novo Nordisk Inc $13.80 06/27/2018 Food and Beverage Undisputed 01/23/2026 588679183 CMS
PFIZER INC. $4.72 01/02/2018 Food and Beverage Undisputed 01/23/2026 610543555 CMS
PFIZER INC. $5.61 01/12/2018 Food and Beverage Undisputed 01/23/2026 610589357 CMS
PFIZER INC. $13.93 01/31/2018 Food and Beverage Undisputed 01/23/2026 610487885 CMS
PFIZER INC. $4.53 06/15/2018 Food and Beverage Undisputed 01/23/2026 610756123 CMS
PFIZER INC. $84.90 06/27/2018 Food and Beverage Undisputed 01/23/2026 610507997 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018
Source files
Dataset page · Bulk file · PY2018
Generated from
OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.